Global Serum Glycated Albumin Assay Market Growth (Status and Outlook) 2025-2031

The global Serum Glycated Albumin Assay market size is predicted to grow from US$ 513 million in 2025 to US$ 741 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Glycated albumin assays are laboratory tests used to measure the levels of glycated albumin in a person"s blood. Glycated albumin is a form of albumin (a protein found in the blood) that has become chemically bonded to glucose.

The global increase in diabetes prevalence is a significant driver for the growth of the Serum Glycated Albumin Assay market. As diabetes becomes more prevalent globally, the demand for accurate and timely biomarkers like glycated albumin for diabetes management grows.

LPI (LP Information)' newest research report, the “Serum Glycated Albumin Assay Industry Forecast” looks at past sales and reviews total world Serum Glycated Albumin Assay sales in 2024, providing a comprehensive analysis by region and market sector of projected Serum Glycated Albumin Assay sales for 2025 through 2031. With Serum Glycated Albumin Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serum Glycated Albumin Assay industry.

This Insight Report provides a comprehensive analysis of the global Serum Glycated Albumin Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Serum Glycated Albumin Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Serum Glycated Albumin Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serum Glycated Albumin Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serum Glycated Albumin Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of Serum Glycated Albumin Assay market by product type, application, key players and key regions and countries.

Segmentation by Type:
Colorimetric Assay
Immunoassay

Segmentation by Application:
Hospital
Diagnostic Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Asahi Kasei
Beijing Strong Biotechnologies
Diazyme Laboratories
DxGen Corp
Weldon Biotech
Hzymes Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.